R'Kes Starling

R'Kes Starling is the founder and CEO of Reveles Clinical Services, a technology and service provider focused on improving access to clinical trials through decentralized clinical trial (DCT) services.12 He has over 18 years of experience in providing high-touch pharmacy services, clinical reach operations, specialty drug distribution, and clinical management for patients with rare and complex diseases.1

Career Background

• Founded Reveles Clinical Services in June 20194
• Previously held leadership roles at McKesson, Coram CVS, and DaVita2
• Headed the Specialty Pharmacy and Clinical Research Service business at McKesson1
• Served as Vice President of Operations at Coram CVS Specialty Infusion Services1
• Worked in retail pharmacy operations management at Wal-Mart, Sam's Club, and Target Stores1

Education

• Bachelor of Science in Pharmacy from Purdue University14
• Executive MBA from Kellogg School of Management, Northwestern University14

Expertise

R'Kes Starling specializes in:

• Decentralized clinical trials (DCTs)
• Clinical research operations
• Specialty pharmacy services
• Patient-centric approaches in clinical trials
• Strategic development and go-to-market execution4

Through Reveles, R'Kes has become an advocate for DCTs, educating the industry on how and why to implement these approaches.2 His company aims to "bring hope closer to home" by enabling patients with rare and complex diseases to participate in clinical trials from the comfort of their homes.3